Tuesday, August 04, 2009

Sun, Medimmune settle over amifostine (ETHYOL)

Sun Pharmaceuticals has settled with Medimmune (Astra Zeneca ) concerning the (Hatch-Waxman) patent dispute over Ethyol (amifostine), a drug which is used to reduce toxicities associated with chemotherapy and radiation in head and neck cancers. Sun had filed a paragraph IV certification, and Medimmune had filed an infringement case in D. Maryland, pursuant to Hatch-Waxman.


Post a Comment

<< Home